Additional File 7: Table S3. of A Pilot Systematic Genomic Comparison of Recurrence Risks of Hepatitis B Virus-Associated Hepatocellular Carcinoma with Low- and High-Degree Liver Fibrosis

Seungyeul Yoo,Wenhui Wang,Qin Wang,M. Isabel Fiel,Eunjee Lee,Spiros P. Hiotis,Jun Zhu

DOI: https://doi.org/10.6084/m9.figshare.5678614

2017-01-01

Abstract:Summary of number of HBV integration sites in BGI samples. (XLSX 45 kb)

What problem does this paper attempt to address?

Additional File 19: Table S11. of A Pilot Systematic Genomic Comparison of Recurrence Risks of Hepatitis B Virus-Associated Hepatocellular Carcinoma with Low- and High-Degree Liver Fibrosis

Seungyeul Yoo,Wenhui Wang,Qin Wang,M. Isabel Fiel,Eunjee Lee,Spiros Hiotis,Jun Zhu

DOI: https://doi.org/10.6084/m9.figshare.5678392

2017-01-01

Abstract:Association between pathogenic mutations and HBV integration host genes. (XLSX 41 kb)
A Pilot Systematic Genomic Comparison of Recurrence Risks of Hepatitis B Virus-Associated Hepatocellular Carcinoma with Low- and High-Degree Liver Fibrosis

Seungyeul Yoo,Wenhui Wang,Qin Wang,M Isabel Fiel,Eunjee Lee,Spiros P. Hiotis,Jun Zhu

DOI: https://doi.org/10.1186/s12916-017-0973-7

IF: 9.3

2017-01-01

BMC Medicine

Abstract:Background: Chronic hepatitis B virus (HBV) infection leads to liver fibrosis, which is a major risk factor in hepatocellular carcinoma (HCC) and an independent risk factor of recurrence after HCC tumor resection. The HBV genome can be inserted into the human genome, and chronic inflammation may trigger somatic mutations. However, how HBV integration and other genomic changes contribute to the risk of tumor recurrence with regards to the different degree of liver fibrosis is not clearly understood. Methods: We sequenced mRNAs of 21 pairs of tumor and distant non-neoplastic liver tissues of HBV-HCC patients and performed comprehensive genomic analyses of our RNAseq data and public available HBV-HCC sequencing data. Results: We developed a robust pipeline for sensitively identifying HBV integration sites based on sequencing data. Simulations showed that our method outperformed existing methods. Applying it to our data, 374 and 106 HBV host genes were identified in non-neoplastic liver and tumor tissues, respectively. When applying it to other RNA sequencing datasets, consistently more HBV integrations were identified in non-neoplastic liver than in tumor tissues. HBV host genes identified in non-neoplastic liver samples significantly overlapped with known tumor suppressor genes. More significant enrichment of tumor suppressor genes was observed among HBV host genes identified from patients with tumor recurrence, indicating the potential risk of tumor recurrence driven by HBV integration in non-neoplastic liver tissues. We also compared SNPs of each sample with SNPs in a cancer census database and inferred samples' pathogenic SNP loads. Pathogenic SNP loads in non-neoplastic liver tissues were consistently higher than those in normal liver tissues. Additionally, HBV host genes identified in non-neoplastic liver tissues significantly overlapped with pathogenic somatic mutations, suggesting that HBV integration and somatic mutations targeting the same set of genes are important to tumorigenesis. HBV integrations and pathogenic mutations showed distinct patterns between low and high liver fibrosis patients with regards to tumor recurrence. Conclusions: The results suggest that HBV integrations and pathogenic SNPs in non-neoplastic tissues are important for tumorigenesis and different recurrence risk models are needed for patients with low and high degrees of liver fibrosis.
Additional File 7 of Single-cell Analysis Reveals HBV-specific PD-1+CD8+ TRM Cells in Tumor Borders Are Associated with HBV-related Hepatic Damage and Fibrosis in HCC Patients

Lulu Liu,Jun-Wei Liu,Pan Li,Jing Luo,Renyi Qin,Peng Qiao,Bin Li,Xuyong Wei,Tian Wang,Hongyu Shi,Mingda Wang,Chao Li,Weijia Fang,Wei Chen,Xin Xu,Yang Tian,Weiwei Yin,Xun Zeng

DOI: https://doi.org/10.6084/m9.figshare.23573783

2023-01-01

Abstract:Additional file 7: Supplemental table 7. Classification of HBV+patients with TB tissues based on the grade of liver disease.
Table S1 from The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients

Bo Zheng,Xiao-Long Liu,Rong Fan,Jian Bai,Hao Wen,Lu-Tao Du,Guo-Qing Jiang,Chun-Ying Wang,Xiao-Tang Fan,Yi-Nong Ye,Yun-Song Qian,Ying-Chao Wang,Gao-Jing Liu,Guo-Hong Deng,Feng Shen,He-Ping Hu,Hui Wang,Qing-Zheng Zhang,Lan-Lan Ru,Jing Zhang,Yan-Hang Gao,Jie Xia,Hua-Dong Yan,Min-Feng Liang,Yan-Long Yu,Fu-Ming Sun,Yu-Jing Gao,Jian Sun,Chun-Xiu Zhong,Yin Wang,Fei Kong,Jin-Ming Chen,Dan Zheng,Yuan Yang,Chuan-Xin Wang,Lin Wu,Jin-Lin Hou,Jing-Feng Liu,Hong-Yang Wang,Lei Chen

DOI: https://doi.org/10.1158/1078-0432.22480616.v1

2023-01-01

Abstract:Table S1
Genome-wide Association Study Identifies 8p21.3 Associated with Persistent Hepatitis B Virus Infection among Chinese.

Yuanfeng Li,Lanlan Si,Yun Zhai,Yanling Hu,Zhibin Hu,Jin-Xin Bei,Bobo Xie,Qian Ren,Pengbo Cao,Fei Yang,Qingfeng Song,Zhiyu Bao,Haitao Zhang,Yuqing Han,Zhifu Wang,Xi Chen,Xia,Hongbo Yan,Rui Wang,Ying Zhang,Chengming Gao,Jinfeng Meng,Xinyi Tu,Xinqiang Liang,Ying Cui,Ying Liu,Xiaopan Wu,Zhuo Li,Huifen Wang,Zhaoxia Li,Bo Hu,Minghui He,Zhibo Gao,Xiaobing Xu,Hongzan Ji,Chaohui Yu,Yi Sun,Baocai Xing,Xiaobo Yang,Haiying Zhang,Aihua Tan,Chunlei Wu,Weihua Jia,Shengping Li,Yi-Xin Zeng,Hongbing Shen,Fuchu He,Zengnan Mo,Hongxing Zhang,Gangqiao Zhou

DOI: https://doi.org/10.1038/ncomms11664

IF: 16.6

2016-01-01

Nature Communications

Abstract:Hepatitis B virus (HBV) infection is a common infectious disease. Here we perform a genome-wide association study (GWAS) among Chinese populations to identify novel genetic loci involved in persistent HBV infection. GWAS scan is performed in 1,251 persistently HBV infected subjects (PIs, cases) and 1,057 spontaneously recovered subjects (SRs, controls), followed by replications in four independent populations totally consisting of 3,905 PIs and 3,356 SRs. We identify a novel locus at 8p21.3 (index rs7000921, odds ratio=0.78, P=3.2 × 10(-12)). Furthermore, we identify significant expression quantitative trait locus associations for INTS10 gene at 8p21.3. We demonstrate that INST10 suppresses HBV replication via IRF3 in liver cells. In clinical plasma samples, we confirm that INST10 levels are significantly decreased in PIs compared with SRs, and negatively correlated with the HBV load. These findings highlight a novel antiviral gene INTS10 at 8p21.3 in the clearance of HBV infection.
Abstract 4891: Hepatitis B Virus Remodels Host Protein Interaction Networks to Generate Distinct Cellular Dependencies

John D. Gordan,Adriana Pitea,Manon Eckhardt,Gwendolyn Jang,Rigney E. Turnham,Alex L M. Choi,John Von Dollen,Huat C. Lim,Elizabeth F. Thayer,R. Katie Kelley,Danielle L. Swaney,Wei Zhang,Fabian J. Theis,Trey Ideker,Nevan J. Krogan

DOI: https://doi.org/10.1158/1538-7445.am2020-4891

IF: 11.2

2020-01-01

Cancer Research

Abstract:Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide. Advanced HCC has proven particularly difficult to treat because of a scarcity of clear genetic drivers of cancer progression; thus, there are currently no predictive markers that guide HCC therapy. HCC arises in the context of co-morbid hepatitis due to hepatitis B virus (HBV), hepatitis C (HCV) or fatty liver disease. We hypothesize that protein-protein interactions (PPIs) between viral proteins and HCC genes may contribute to tumor initiation and maintenance. In order to characterize these PPIs, we performed affinity purification - mass spectrometry (APMS), defining 145 HBV/host PPIs including known and novel interacting partners. We next used a network propagation algorithm to identify host genes and protein complexes that were preferentially mutated in the absence of HBV infection. HBV is a small DNA virus, with 4 genes of which only one has enzymatic activity, raising a question as to how HBV interaction modifies host behavior. Using AP-MS of host proteins, we found that the HBV X protein (HBx) remodels multiple host protein complexes through direct interaction. These physical effects on complex components result in distinct biochemical behavior from the CRL4 E3 ubiquitin ligase complex as well as the phosphatase PP2A, as determined through global phosphoproteomics and ubiquitin analysis. We show that this remodeling driven by HBx substantially changes cellular protein turnover and downstream signaling dynamics. We followed this up with assessments of cellular viability and proliferation in response to pharmacological inhibition or CRISPRi-based knockdown of HBx effectors. Our data support a model where HBV proteins alter the components and behavior of key regulatory protein complexes in the cell, altering tumor behavior and raising the possibility of precision therapeutics for HCC. Citation Format: John D. Gordan, Adriana Pitea, Manon Eckhardt, Gwendolyn Jang, Rigney E. Turnham, Alex L M. Choi, John Von Dollen, Huat C. Lim, Elizabeth F. Thayer, R. Katie Kelley, Danielle L. Swaney, Wei Zhang, Fabian J. Theis, Trey Ideker, Nevan J. Krogan. Hepatitis B virus remodels host protein interaction networks to generate distinct cellular dependencies [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 4891.
Recurrent Targeted Genes of Hepatitis B Virus in the Liver Cancer Genomes Identified by a Next-Generation Sequencing–Based Approach

Dong Ding,Xiaoyan Lou,Dasong Hua,Wei Yu,Lisha Li,Jun Wang,Feng Gao,Na Zhao,Guoping Ren,Lanjuan Li,Biaoyang Lin

DOI: https://doi.org/10.1371/journal.pgen.1003065

IF: 4.5

2012-12-06

PLoS Genetics

Abstract:Integration of the viral DNA into host chromosomes was found in most of the hepatitis B virus (HBV)-related hepatocellular carcinomas (HCCs). Here we devised a massive anchored parallel sequencing (MAPS) method using next-generation sequencing to isolate and sequence HBV integrants. Applying MAPS to 40 pairs of HBV-related HCC tissues (cancer and adjacent tissues), we identified 296 HBV integration events corresponding to 286 unique integration sites (UISs) with precise HBV-Human DNA junctions. HBV integration favored chromosome 17 and preferentially integrated into human transcript units. HBV targeted genes were enriched in GO terms: cAMP metabolic processes, T cell differentiation and activation, TGF beta receptor pathway, ncRNA catabolic process, and dsRNA fragmentation and cellular response to dsRNA. The HBV targeted genes include 7 genes (PTPRJ, CNTN6, IL12B, MYOM1, FNDC3B, LRFN2, FN1) containing IPR003961 (Fibronectin, type III domain), 7 genes (NRG3, MASP2, NELL1, LRP1B, ADAM21, NRXN1, FN1) containing IPR013032 (EGF-like region, conserved site), and three genes (PDE7A, PDE4B, PDE11A) containing IPR002073 (3', 5'-cyclic-nucleotide phosphodiesterase). Enriched pathways include hsa04512 (ECM-receptor interaction), hsa04510 (Focal adhesion), and hsa04012 (ErbB signaling pathway). Fewer integration events were found in cancers compared to cancer-adjacent tissues, suggesting a clonal expansion model in HCC development. Finally, we identified 8 genes that were recurrent target genes by HBV integration including fibronectin 1 (FN1) and telomerase reverse transcriptase (TERT1), two known recurrent target genes, and additional novel target genes such as SMAD family member 5 (SMAD5), phosphatase and actin regulator 4 (PHACTR4), and RNA binding protein fox-1 homolog (C. elegans) 1 (RBFOX1). Integrating analysis with recently published whole-genome sequencing analysis, we identified 14 additional recurrent HBV target genes, greatly expanding the HBV recurrent target list. This global survey of HBV integration events, together with recently published whole-genome sequencing analyses, furthered our understanding of the HBV-related HCC.

genetics & heredity
Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Yufei Wang,Man Zhao,Lina Zhao,Yu Geng,Guanghao Li,Lin Chen,Jingxuan Yu,Hongfeng Yuan,Huihui Zhang,Haolin Yun,Ying Yuan,Guowen Wang,Jinyan Feng,Liang Xu,Shuai Wang,Chunyu Hou,Guang Yang,Ningning Zhang,Wei Lu,Xiaodong Zhang

DOI: https://doi.org/10.1158/0008-5472.22433561.v1

2023-01-01

Abstract:Supplementary materials and methods, Supplementary figures, Supplementary figure legends, Supplementary tables
The Effects of Hepatitis B Virus Integration into the Genomes of Hepatocellular Carcinoma Patients

Zhaoshi Jiang,Suchit Jhunjhunwala,Jinfeng Liu,Peter M. Haverty,Michael I. Kennemer,Yinghui Guan,William Lee,Paolo Carnevali,Jeremy Stinson,Stephanie Johnson,Jingyu Diao,Stacy Yeung,Adrian Jubb,Weilan Ye,Thomas D. Wu,Sharookh B. Kapadia,Frederic J. de Sauvage,Robert C. Gentleman,Howard M. Stern,Somasekar Seshagiri,Krishna P. Pant,Zora Modrusan,Dennis G. Ballinger,Zemin Zhang

DOI: https://doi.org/10.1101/gr.133926.111

IF: 9.438

2012-01-01

Genome Research

Abstract:Hepatitis B virus (HBV) infection is a leading risk factor for hepatocellular carcinoma (HCC). HBV integration into the host genome has been reported, but its scale, impact and contribution to HCC development is not clear. Here, we sequenced the tumor and nontumor genomes (>80× coverage) and transcriptomes of four HCC patients and identified 255 HBV integration sites. Increased sequencing to 240× coverage revealed a proportionally higher number of integration sites. Clonal expansion of HBV-integrated hepatocytes was found specifically in tumor samples. We observe a diverse collection of genomic perturbations near viral integration sites, including direct gene disruption, viral promoter-driven human transcription, viral-human transcript fusion, and DNA copy number alteration. Thus, we report the most comprehensive characterization of HBV integration in hepatocellular carcinoma patients. Such widespread random viral integration will likely increase carcinogenic opportunities in HBV-infected individuals.
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

Wing-Kin Sung,Hancheng Zheng,Shuyu Li,Ronghua Chen,Xiao Liu,Yingrui Li,Nikki P Lee,Wah H Lee,Pramila N Ariyaratne,Chandana Tennakoon,Fabianus H Mulawadi,Kwong F Wong,Angela M Liu,Ronnie T Poon,Sheung Tat Fan,Kwong L Chan,Zhuolin Gong,Yujie Hu,Zhao Lin,Guan Wang,Qinghui Zhang,Thomas D Barber,Wen-Chi Chou,Amit Aggarwal,Ke Hao,Wei Zhou,Chunsheng Zhang,James Hardwick,Carolyn Buser,Jiangchun Xu,Zhengyan Kan,Hongyue Dai,Mao Mao,Christoph Reinhard,Jun Wang,John M Luk

DOI: https://doi.org/10.1038/ng.2295

IF: 30.8

2012-05-27

Nature Genetics

Abstract:John Luk and colleagues report the sequencing of 81 hepatitis B virus (HBV)-positive and 7 HBV-negative hepatocellular carcinomas and matched normal tissues. They confirm recurrent integration events of HBV at TERT and MLL4 and report recurrent events at the CCNE1 gene.

genetics & heredity
Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Wei Wu,Yu Chen,Bing Ruan,Lan-Juan Li

2005-01-01

Abstract:BACKGROUND:The pathogenesis of severe hepatitis B remains unknown. Reports have indicated that hepatitis B virus (HBV) mutations are important factors in the pathogenesis of this disease. This study was to investigate the genetic heterogeneity of HBV strains from serum samples of patients with fulminant hepatitis B.METHODS:Full-length HBV genomes from 4 patients with severe hepatitis B were cloned and sequenced to observe mutations in every open reading-frame (ORF). Serum samples of another 25 patients with severe hepatitis B, 30 patients with chronic hepatitis B, and 25 HBV carriers were collected for sequencing and comparison of mutations in preS2, preC and core promoter regions.RESULTS:Of 4 HBV full-length genome sequences, 3 had a G to A mutation at nucleotide A1896 in the preC region and 1 had double mutations of T1762-A1764 in the core promoter region. The 4 sequences showed mutations in the known B or T cell epitopes of the preS2 and C regions. For the other 3 groups, more mutations were seen in the preS2 region in the HBV isolates from the patients with severe hepatitis B than those from the patients with chronic hepatitis B and HBV carriers (P<0.01). There was a significant difference of mutations in the T cell epitope region of preS2 between the patients with severe hepatitis B and those with chronic hepatitis B or HBV carriers (P<0.01). In the preC and core promoter regions, the mutation frequencies of T1653 and C1753 were 48.0% and 24.0% respectively in the patients with severe hepatitis B, but none of these mutations were observed in the patients with chronic hepatitis B group or HBV carriers (P<0.01). The mutation frequency of T1762-A1764 was 76.0% in the patients with severe hepatitis B, 40.0% in the patients with chronic hepatitis B (P<0.01), and 16.0% in the HBV carriers (P<0.01). There was a significant difference in A1896 mutation between the patients with severe hepatitis B and the patients with chronic hepatitis B (P<0.05) or the HBV carriers (P<0.05).CONCLUSION:Our observations suggest that the accumulation and persistence of high frequency mutations or complex mutations may be associated with the development and deterioration of HBV infection.
Full-length Genomic Analysis of Hepatitis B Virus Isolates in a Patient Progressing from Hepatitis to Hepatocellular Carcinoma.

X Lin,GS Qian,PX Lu,L Wu,YM Wen

DOI: https://doi.org/10.1002/jmv.1050

IF: 20.693

2001-01-01

Journal of Medical Virology

Abstract:In hepatitis B virus (HBV)-endemic countries, the majority of hepatocellular carcinoma (HCC) arises in HBV carriers. High frequency of mutations at nucleotides 1762(A-->T) and 1764(G-->A) in the core promoter region have been described in HCC. Due to the differences in genetic backgrounds, environmental risk factors and random cellular insertion sites, it is difficult to analyze the possible roles of HBV variants detected in different HCC patients. In a follow-up cohort study, an HBsAg-positive asymptomatic carrier was diagnosed HCC within 4 years. Eleven full-length HBV isolates, three from the first serum sample obtained 4 years pre-HCC, and eight from serum sample, peri-tumor and tumor tissue post-HCC of this individual were sequenced and used to transfect HepG2 cells. When sequences were compared between pre- and post-HCC isolates, no single mutation common to all post-HCC isolates that differed from pre-HCC isolates was found. Among all 11 isolates, there were 20 predicted amino acid substitutions shared by two or more post-HCC isolates. These were located in the S(5), X(4), core(4), polymerase(4), pre-S1(2) and pre-S2(1) proteins. Possible roles of amino acid substitutions and enhanced replication efficiency in cells transfected by post-HCC isolates are discussed.
Supplementary Methods, Supplementary Figures 1-10, Supplementary Tables 1-17, Supplementary References from Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus–Related Hepatocellular Carcinoma

Yuanfeng Li,Yun Zhai,Qingfeng Song,Haitao Zhang,Pengbo Cao,Jie Ping,Xinyi Liu,Bingqian Guo,Guanjun Liu,Jin Song,Ying Zhang,Aiqing Yang,Hongbo Yan,Liang Yang,Ying Cui,Yilong Ma,Jinliang Xing,Xizhong Shen,Taotao Liu,Hongxin Zhang,Jiaze An,Jin-Xin Bei,Weihua Jia,Longli Kang,Lijun Liu,Dongya Yuan,Zhibin Hu,Hongbing Shen,Lei Lu,Xuan Wang,Hua Li,Fuchu He,Hongxing Zhang,Gangqiao Zhou

DOI: https://doi.org/10.1158/1078-0432.22464834.v1

2023-01-01

Abstract:Supplementary Figure 1. An overview of the study workflow; Supplementary Figure 2. The principal components analyses (PCA) of samples in the discovery stage and reference samples from the 1000 Genomes Project data. Supplementary Figure 3. Manhattan plots of the genome-wide P values from the association tests on HBV-related HCC. Supplementary Figure 4. Quantile-quantile plots of the observed P values from the association tests on HBV-related HCC. Supplementary Figure 5. Forest plots for rs10272859 across all studies. Supplementary Figure 6. Expression levels of CDK14 mRNA were significantly higher in HCC tissues compared with adjacent non-tumor liver tissues. Supplementary Figure 7. The at-risk G allele of rs10272859 was significantly associated with higher mRNA levels of CDK14 in liver tissues based on the TCGA data. Supplementary Figure 8. The SNPs at 7q21.13 interact physically with the promoter region of CDK14 in GM12878 cells. Supplementary Figure 9. Kaplan-Meier estimates of the overall survival time for the HCC patients stratified by CDK14 mRNA expression levels. Supplementary Figure 10. Kaplan-Meier estimates of disease-free survival time for patients with HBV-related HCC stratified by genotypes of rs10272859. Supplementary Table 1. Summary description of the populations used in this study. Supplementary Table 2. Summary of the quality controls in proband-parent trios. Supplementary Table 3. Summary of SNP imputation in the discovery stage. Supplementary Table 4. The amount of SNPs with various P values in TDT for the 189 trios in the discovery stage. Supplementary Table 5. Summary of the SNPs that have been reported significantly associated with HBV-related HCC in previous GWASs. Supplementary Table 6. Summary of SNPs that have been reported to be significantly associated with HBV-related phenotypes in previous GWASs. Supplementary Table 6. Summary of SNPs that have been reported to be significantly associated with HBV-related phenotypes in previous GWASs (Continued). Supplementary Table 7. Summary of the top 15 SNPs in the discovery stage. Supplementary Table 8. Primers and probes used in this study. Supplementary Table 9. Summary of the replication studies for the 14 SNPs newly identified in the discovery stage. Supplementary Table 10. Stratification analyses of rs10272859 by gender and age. Supplementary Table 11. The associations between genotypes of rs10272859 and mRNA levels of nearby genes. Supplementary Table 12. The predicted functional relevance of rs10272859 and the other 74 SNPs in strong linkage disequilibrium with rs10272859 at the ~110 Kb region of 7q21.13. Supplementary Table 13. Details for the genotypes of rs10272859 and the prognosis of patients with HBV-related HCC. Supplementary Table 14. Multivariate analyses of overall survival time and disease-free survival time of patients with HBV-related HCC. Supplementary Table 15. Genotype distribution of rs10272859 across TNM stages in patients with HBV-related HCC. Supplementary Table 16. Powers for various genetic effects and various minor allele frequencies. Supplementary Table 17. The allele and genotype frequencies of rs10272859 in different populations.
Comparison Study on the Complete Sequence of Hepatitis B Virus Identifies New Mutations in Core Gene Associated with Hepatocellular Carcinoma

Yu Zhu,Yan Jin,Xia Guo,Xin Bai,Taoyang Chen,Jinbing Wang,Gengsun Qian,John D. Groopman,Jianren Gu,Jinjun Li,Hong Tu

DOI: https://doi.org/10.1158/1055-9965.epi-10-0469

2010-01-01

Abstract:Background: Mutations in the hepatitis B virus (HBV) genome may influence the activity of liver disease. The aim of this study was to identify new viral variations associated with hepatocellular carcinoma (HCC). Methods: We carried out a comparison study on the complete sequence of HBV isolated from 20 HCC and 35 non-HCC patients in Qidong, China, an area with a high incidence of HCC. We compared the HBV sequences in a consecutive series of plasma samples from four HCC cases before and after the occurrence of HCC. In addition, we selected four mutations in the HBV core (C) gene to verify their relationships to HCC in an independent set of 103 HCC cases and 103 sex- and age-matched non-HCC controls. Results: The pre-S deletion and 12 point mutations, namely, the pre-S2 start codon mutation, T53C in the pre-S2 gene, T766A in the S gene, G1613A, C1653T, A1762T, G1764A in the X gene, and G1899A, C2002T, A2159G, A2189C, and G2203W (A or T) in the pre-C/C gene, showed close associations with HCC. In the validation study, A2159G, A2189C, and G2203W showed consistent associations with HCC by univariate analysis. Multivariate analysis showed that A2189C and G2203W were independent risk factors for HCC. The odds ratios (95% confidence interval) were 3.99 (1.61-9.92) and 9.70 (1.17-80.58), respectively, for A2189C and G2203W. Conclusions: These results implicate A2189C and G2203W as new predictive markers for HCC. Impact: The complete genome analysis of HBV provided pilot data for the identification of novel mutations that could serve as markers for HCC. Cancer Epidemiol Biomarkers Prev; 19(10); 2623–30. ©2010 AACR.
Distinct Hepatitis B Virus Integration Patterns in Hepatocellular Carcinoma and Adjacent Normal Liver Tissue

Xiaobo Yang,Liangcai Wu,Jianzhen Lin,Anqiang Wang,Xueshuai Wan,Yan Wu,Simon C. Robson,Xinting Sang,Haitao Zhao

DOI: https://doi.org/10.1002/ijc.30547

2017-01-01

International Journal of Cancer

Abstract:Infection by the hepatitis B virus (HBV) is one of the main etiologies of hepatocellular carcinoma (HCC). During chronic infection, HBV DNA can integrate into the human genome, and this has been postulated as a possible mechanism of HBV-induced HCC. In this study we used 2199 HBV integration sites from Dr. VIS v2.0 and mapped them to the human genome (hg19) to obtain viral integration sites (VIS) related to protein-coding and non-protein-coding genes. In total, we found 1,377 and 767 VIS within close proximity to protein coding genes and noncoding genes, respectively. Genes affected more than two times included 23.1% of protein-coding genes and 24.7% of long noncoding RNAs (lncRNA). Only 4.8% of VIS were shared between HCC and non-tumor tissues. HBV integrations were more common in chromosomes 5, 8, 10, and 19 in HCC tissue and chromosomes 1 and 2 in non-tumorous tissue. The number of integration sites on each chromosome correlated with the number of fragile sites in nontumorous tissue but not in HCC tissue. Functional enrichment analysis of the protein-coding genes containing or in close proxim-ity to HBV integration sites in HCC tissue showed an enrichment of cancer related gene ontology terms. Additionally, the most frequently associated lncRNA genes were related to telomere maintenance, protein modification processes, and chromosome localization. Thus, HBV may have preferred integration sites in the human genome that serve a critical role in HCC development. These results show that HCC treatment may benefit from the development of next generation anti-viral therapies.
Identification of Hepatitis B Virus Integration Sites in Hepatocellular Carcinoma Tissues from Patients with Chronic Hepatitis B

Hong Tu,Hai-feng Gao,Guo-ha Ma,Yi Liu

DOI: https://doi.org/10.3760/j:issn:0376-2491.2006.18.007

2006-01-01

Abstract:OBJECTIVE:Hepatitis B virus (HBV) integration into the host genome is frequently detected in HBV positive hepatocellular carcinoma (HCC) in China. The aim of this study is to carry out a large-scale screening for the HBV integrations sites in HCC samples from Chinese patients.METHODS:Cellular DNA was extracted from 40 HBV-related HCC by proteinase K digestion/phenol extraction method. One primer specific to HBV sequence and another primer directed to human Alu repeat were used to amplify the virus/cellular DNA junction. To avoid undesirable amplifications between Alu sequences, primers were constructed with dUTPs and destroyed by uracil DNA glycosylase treatment after 15 initial cycles of amplification. Only desirable fragments were then further amplified with specific primers to the known region and to a tag sequence introduced in the Alu-Specific primer. The PCR product was purified and subject to direct sequencing by ABI 3700 Auto sequencer. NCBI (national center for biotechnology information) BLAST and MapViewer search were used for identification of HBV location on human genomes.RESULTS:In 40 HBsAg positive HCC samples, 34 (85%) were showed to have at least one copy of HBV fragment in host genome, indicating HBV-Alu-PCR is a rapid way for identification of new cellular DNA sequences adjacent to HBV. Analysis from the 68 isolated viral-cellular junctions, X gene was found to be interrupted at any length, not specifically at DR1 and DR2 regions. Three-prime-deleted X gene was observed in 65 (96%) cases. HBV preferred to integrate into the intron and the up-stream regulatory region of the cellular genes. In no case HBV inserted into the exon. Our results also demonstrated that the cellular genes targeted by HBV are usually key regulators of cell proliferation and cell death. Three genes, myeloid/lymphoid or mixed-lineage leukemia 4, G protein alpha transducing activity polypeptide 1 and fibronectin, were found to be recurrently targeted by HBV.CONCLUSION:HBV-Alu-PCR is a powerful tool for the study of HBV integration sites. Truncated X is a major form existed in the HBV integrants. HBV integration is not distributed evenly throughout the host genome and viral insertional mutagenesis may play an important role in the development of HCC.
Complete Genome Sequencing and Clinical Analysis of Intrahepatic Hepatitis B Virus Cccdna from HCC.

Fengping Jiao,Lu Long,Shanlong Ding,Xiaomeng Xie,Le Jia,Fengmin Lu

DOI: https://doi.org/10.1016/j.micpath.2017.04.028

IF: 3.848

2017-01-01

Microbial Pathogenesis

Abstract:Background: More than half of hepatocellular carcinomas (HCCs) are etiologically attributed to hepatitis B virus (HBV) infection, but it remains unclear whether HBV mutations are virological factors that contribute to formation of HCC or instead reflect accumulation during the progression of HBV-related disease.Methods: Rolling-cycle amplification and PCR sequencing were used to characterize covalently closed circular DNA (cccDNA) mutations in tumor tissues. Paired non-tumor tissues were used as controls.Results: High frequencies of C1653T, T1753V, and A1762T/G1764A cccDNA mutations were observed in both tumor and non-tumor tissues. T1719G, C1329A, and T3098C mutations were related to the overall survival of HCC patients. Patients with G1719 tended to be in the high Barcelona Clinic Liver Cancer stage and had lower levels of total DNA and cccDNA per cell than patients with T1719. Additionally, in vitro analysis revealed that T1719G mutation reduced viral replication efficacy. Finally, significantly higher levels of preoperative alpha-fetoprotein were observed in patients harboring the G1078T, C1653T, G1727A, C1913A, T1978C, or C3116T mutations at the cccDNA level.Conclusions: We speculated that HBV cccDNA mutations accumulated over the course of HBV-related disease development, and that some key mutations had prognostic value for patients with HBVrelated HCC. (C) 2017 Elsevier Ltd. All rights reserved.
Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma

Ling-Hao Zhao,Xiao Liu,He-Xin Yan,Wei-Yang Li,Xi Zeng,Yuan Yang,Jie Zhao,Shi-Ping Liu,Xue-Han Zhuang,Chuan Lin,Chen-Jie Qin,Yi Zhao,Ze-Ya Pan,Gang Huang,Hui Liu,Jin Zhang,Ruo-Yu Wang,Yun Yang,Wen Wen,Gui-Shuai Lv,Hui-Lu Zhang,Han Wu,Shuai Huang,Ming-Da Wang,Liang Tang,Hong-Zhi Cao,Ling Wang,Tin-Lap Lee,Hui Jiang,Ye-Xiong Tan,Sheng-Xian Yuan,Guo-Jun Hou,Qi-Fei Tao,Qin-Guo Xu,Xiu-Qing Zhang,Meng-Chao Wu,Xun Xu,Jun Wang,Huan-Ming Yang,Wei-Ping Zhou,Hong-Yang Wang

DOI: https://doi.org/10.1038/ncomms12992

IF: 16.6

2016-10-05

Nature Communications

Abstract:Abstract Hepatitis B virus (HBV) can integrate into the human genome, contributing to genomic instability and hepatocarcinogenesis. Here by conducting high-throughput viral integration detection and RNA sequencing, we identify 4,225 HBV integration events in tumour and adjacent non-tumour samples from 426 patients with HCC. We show that HBV is prone to integrate into rare fragile sites and functional genomic regions including CpG islands. We observe a distinct pattern in the preferential sites of HBV integration between tumour and non-tumour tissues. HBV insertional sites are significantly enriched in the proximity of telomeres in tumours. Recurrent HBV target genes are identified with few that overlap. The overall HBV integration frequency is much higher in tumour genomes of males than in females, with a significant enrichment of integration into chromosome 17. Furthermore, a cirrhosis-dependent HBV integration pattern is observed, affecting distinct targeted genes. Our data suggest that HBV integration has a high potential to drive oncogenic transformation.

multidisciplinary sciences
Disparity landscapes of viral-induced structural variations in HCC: Mechanistic characterization and functional implications

Xueying Lyu,Karen Man-Fong Sze,Joyce Man-Fong Lee,Abdullah Husain,Lu Tian,Sandrine Imbeaud,Jessica Zucman-Rossi,Irene Oi-Lin Ng,Daniel Wai-Hung Ho

DOI: https://doi.org/10.1097/HEP.0000000000001087

IF: 17.298

2024-09-13

Hepatology

Abstract:Background and aims: HCC is the most common type of primary liver cancer and is a common malignancy worldwide. About half of all new liver cancers worldwide each year occur in China, including Hong Kong, due to a high prevalence of HBV infection. HBV DNA integrates into the human genome, disrupting the endogenous tumor suppressors/regulatory genes or enhancing the activity of proto-oncogenes. It would be useful to examine the different NGS-based databases to provide a more unbiased and comprehensive survey of HBV integration. Approach and results: We aimed to take advantage of publicly available data sets of different regional cohorts to determine the disparity landscapes of integration events among sample cohorts, tissue types, chromosomal positions, individual host, and viral genes, as well as genic locations. By comparing HCC tumors with non tumorous livers, the landscape of HBV integration was delineated in gene-independent and gene-dependent manners. Moreover, we performed mechanistic investigations on how HBV-TERT integration led to TERT activation and derived a score to predict patients' prognostication according to their clonal disparity landscape of HBV integration. Conclusions: Our study uncovered the different levels of clonal enrichment of HBV integration and identified mechanistic insights and prognostic biomarkers. This strengthens our understanding of HBV-associated hepatocarcinogenesis.
Additional File 4 of Clonal Evolution in Liver Cancer at Single-Cell and Single-Variant Resolution

Xianbin Su,Linan Zhao,Yi Shi,Rui Zhang,Qi Long,Shihao Bai,Qing Luo,Yingxin Lin,Xin Zou,Shila Ghazanfar,Kun Tao,Guoliang Yang,Lan Wang,Kunyan He,Xiaofang Cui,Jian He,Jiaoxiang Wu,Bo Han,Bin Yan,Biao Deng,Na Wang,Xin Li,Pengyi Yang,Shangwei Hou,Jingyong Sun,Jean Yee Hwa Yang,Jinhong Chen,Ze‐Guang Han

DOI: https://doi.org/10.6084/m9.figshare.13698268

2021-01-01

Abstract:Additional file 4: Table S2. Mutation sites and amplification primers for single-cell target sequencing. This table shows the full list of target sites and PCR primers used in single-cell target amplification for HCC1, HCC2, HCC9 and HCC8. The primer sequences include the adaptor sequences that can be used for downstream library preparation with illumina Nextera XT Index Kit and multi-plexed sequencing.

Additional File 7: Table S3. of A Pilot Systematic Genomic Comparison of Recurrence Risks of Hepatitis B Virus-Associated Hepatocellular Carcinoma with Low- and High-Degree Liver Fibrosis

Additional File 19: Table S11. of A Pilot Systematic Genomic Comparison of Recurrence Risks of Hepatitis B Virus-Associated Hepatocellular Carcinoma with Low- and High-Degree Liver Fibrosis

A Pilot Systematic Genomic Comparison of Recurrence Risks of Hepatitis B Virus-Associated Hepatocellular Carcinoma with Low- and High-Degree Liver Fibrosis

Additional File 7 of Single-cell Analysis Reveals HBV-specific PD-1+CD8+ TRM Cells in Tumor Borders Are Associated with HBV-related Hepatic Damage and Fibrosis in HCC Patients

Table S1 from The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients

Genome-wide Association Study Identifies 8p21.3 Associated with Persistent Hepatitis B Virus Infection among Chinese.

Abstract 4891: Hepatitis B Virus Remodels Host Protein Interaction Networks to Generate Distinct Cellular Dependencies

Recurrent Targeted Genes of Hepatitis B Virus in the Liver Cancer Genomes Identified by a Next-Generation Sequencing–Based Approach

Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

The Effects of Hepatitis B Virus Integration into the Genomes of Hepatocellular Carcinoma Patients

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Full-length Genomic Analysis of Hepatitis B Virus Isolates in a Patient Progressing from Hepatitis to Hepatocellular Carcinoma.

Supplementary Methods, Supplementary Figures 1-10, Supplementary Tables 1-17, Supplementary References from Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus–Related Hepatocellular Carcinoma

Comparison Study on the Complete Sequence of Hepatitis B Virus Identifies New Mutations in Core Gene Associated with Hepatocellular Carcinoma

Distinct Hepatitis B Virus Integration Patterns in Hepatocellular Carcinoma and Adjacent Normal Liver Tissue

Identification of Hepatitis B Virus Integration Sites in Hepatocellular Carcinoma Tissues from Patients with Chronic Hepatitis B

Complete Genome Sequencing and Clinical Analysis of Intrahepatic Hepatitis B Virus Cccdna from HCC.

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma

Disparity landscapes of viral-induced structural variations in HCC: Mechanistic characterization and functional implications

Additional File 4 of Clonal Evolution in Liver Cancer at Single-Cell and Single-Variant Resolution